{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:15:44Z","timestamp":1770995744794,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T00:00:00Z","timestamp":1336176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00520-012-1481-0","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T08:24:33Z","timestamp":1336119873000},"page":"1585-1587","source":"Crossref","is-referenced-by-count":3,"title":["Lenalidomide cutaneous adverse event: a case of Stevens\u2013Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone"],"prefix":"10.1007","volume":"20","author":[{"given":"A.","family":"Siniscalchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Morino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dentamaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De Bellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Perrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"de Fabritiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Caravita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,5]]},"reference":[{"key":"1481_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR Study. J Invest Dermatol 128:35\u201344","journal-title":"J Invest Dermatol"},{"key":"1481_CR2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","volume":"351","author":"DS Becker","year":"1998","unstructured":"Becker DS (1998) Toxic epidermal necrolysis. Lancet 351:1417\u20131420","journal-title":"Lancet"},{"key":"1481_CR3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"1481_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) A clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"key":"1481_CR5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern S, Anderson T et al (1995) Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600\u20131607","journal-title":"N Engl J Med"},{"issue":"1","key":"1481_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.2008.20.3737","volume":"27","author":"CP Castaneda","year":"2009","unstructured":"Castaneda CP, Brandenburg NA, Bwire R, Burton GH, Zeldis JB (2009) Erythema multiforme\/Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in lenalidomide-treated patients. J Clin Oncol 27(1):156\u2013157","journal-title":"J Clin Oncol"},{"key":"1481_CR7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/annonc\/mdf350","volume":"13","author":"S Lowndes","year":"2002","unstructured":"Lowndes S, Darby A, Mead G, Lister A (2002) Stevens\u2013Johnson syndrome after treatment with rituximab. Ann Oncol 13:1948\u20131950","journal-title":"Ann Oncol"},{"key":"1481_CR8","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2002-12-3696","volume":"101","author":"B Sanchez-Gonzalez","year":"2003","unstructured":"Sanchez-Gonzalez B, Pascual-Ramirez JC, Fernandez-Abellan P, Belinchon-Romero I, Rivas C, Vegara-Aguilera G (2003) Severe skin reaction to imatinib in a case of Philadelphia-positive lymphoblastic leukemia. Blood 101:2446","journal-title":"Blood"},{"key":"1481_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000102604","volume":"118","author":"B Fang","year":"2007","unstructured":"Fang B, Song Y, Ma J, Zhao RC (2007) Severe epidermal necrolysis after bortezomib treatment for multiple myeloma. Acta Haematol 118:65\u201367","journal-title":"Acta Haematol"},{"issue":"13","key":"1481_CR10","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/blood-2005-07-2817","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Geyer SM, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA (2005) Combination therapy with lenalidomide plus dexamethasone (Rev\/Dex) for newly diagnosed myeloma. Blood 106(13):4050\u20134053","journal-title":"Blood"},{"key":"1481_CR11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archderm.142.10.1298","volume":"142","author":"HP Sviggum","year":"2006","unstructured":"Sviggum HP, Davis MDP, Rajkumar V, Dispenzieri A (2006) Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma. Arch Dermatol 142:1298\u20131302","journal-title":"Arch Dermatol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1481-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1481-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1481-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:17Z","timestamp":1559095457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1481-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,5]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1481-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,5]]}}}